Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WNS
326
DELISTED
WNS Holdings
WNS
| $11.8M | 0.01% |
143,699
-36,616
| -20% | -$2.99M |
|
327
Curtiss-Wright
CW
$26.4B
| $11.7M | 0.01% |
92,711
-942
| -1% | -$113K |
|
328
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.44B
| $11.4M | 0.01% |
311,314
-1,479
| -0.5% | -$53.1K |
|
329
Bristol-Myers Squibb
BMY
$131B
| $11.3M | 0.01% |
191,733
+18,040
| +10% | +$1.19M |
|
330
iShares MSCI France ETF
EWQ
$343M
| $11M | 0.01% |
296,141
-6,347
| -2% | -$243K |
|
331
Revvity
RVTY
$12.7B
| $10.9M | 0.01% |
63,149
-2,260
| -3% | -$398K |
|
332
United Rentals
URI
$72.4B
| $10.9M | 0.01% |
30,979
-93
| -0.3% | -$31.2K |
|
|
FLGE
333
DELISTED
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
| $10.8M | 0.01% |
15,393
-1,721
| -10% | -$1.28M |
|
334
ACI Worldwide
ACIW
$5.61B
| $10.8M | 0.01% |
351,773
+42,059
| +14% | +$1.4M |
|
|
SWN
335
DELISTED
Southwestern Energy Company
SWN
| $10.4M | 0.01% |
1,875,559
-2,092,453
| -53% | -$10.2M |
|
|
NTUS
336
DELISTED
Natus Medical Inc
NTUS
| $10.3M | 0.01% |
411,883
-27,455
| -6% | -$700K |
|
337
Materion
MTRN
$5.79B
| $10.3M | 0.01% |
149,909
+4,003
| +3% | +$286K |
|
|
AYX
338
DELISTED
Alteryx Inc
AYX
| $10.2M | 0.01% |
139,237
+10,804
| +8% | +$813K |
|
339
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| $10.2M | 0.01% |
118,018
+2,127
| +2% | +$183K |
|
340
Builders FirstSource
BLDR
$7.8B
| $9.87M | 0.01% |
190,754
+17,441
| +10% | +$852K |
|
|
B
341
DELISTED
Barnes Group Inc.
B
| $9.85M | 0.01% |
236,004
+4
| +0% | +$191 |
|
342
TechnipFMC
FTI
$27.3B
| $9.59M | 0.01% |
1,272,996
+61,304
| +5% | +$441K |
|
343
Lantheus
LNTH
$6.6B
| $9.58M | 0.01% |
373,035
+328,365
| +735% | +$8.58M |
|
344
Synopsys
SNPS
$77.7B
| $9.46M | 0.01% |
31,579
+12,175
| +63% | +$3.7M |
|
345
Baker Hughes
BKR
$62.3B
| $9.25M | 0.01% |
374,133
+60,557
| +19% | +$1.35M |
|
346
ProPetro Holding
PUMP
$1.34B
| $9.06M | 0.01% |
1,047,540
-693,398
| -40% | -$5.42M |
|
347
ICU Medical
ICUI
$4.16B
| $8.87M | 0.01% |
38,000
| – | – |
|
348
LivaNova
LIVN
$4.16B
| $8.83M | 0.01% |
111,457
-1,735
| -2% | -$143K |
|
349
PepsiCo
PEP
$189B
| $8.82M | 0.01% |
58,653
+1,071
| +2% | +$166K |
|
350
UFP Industries
UFPI
$5.19B
| $8.79M | 0.01% |
129,359
-6,600
| -5% | -$479K |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.